Bayer AG
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BAYRY research report →
About the company
Bayer Aktiengesellschaft, commonly known as Bayer AG, functions as a prominent global life sciences company through its various subsidiaries. Its extensive operations are strategically segmented into Pharmaceuticals, Consumer Health, and Crop Science. The Pharmaceuticals division concentrates on developing and marketing prescription medications, with key areas including cardiology and women's healthcare.
- CEO
- William N. Anderson
- IPO
- 1996
- Employees
- 90,587
- HQ
- Leverkusen, DE
Price Chart
- Market Cap
- $59.69B
- P/E
- -24.31
- P/S
- 1.16
- P/B
- 1.82
- EV/EBITDA
- 24.41
- Div Yield
- 0.21%
- Gross Margin
- 59.32%
- Op Margin
- 15.38%
- Net Margin
- -4.77%
- ROE
- -7.52%
- ROIC
- 8.42%
- Revenue
- $43.78B · -6.07%
- Net Income
- $-3,477,128,000 · -36.25%
- EPS
- $-0.88 · -36.15%
- Op Income
- $6.68B
- FCF YoY
- -56.39%
- 52W High
- $15.23
- 52W Low
- $7.19
- 50D MA
- $11.14
- 200D MA
- $10.58
- Beta
- 0.83
- Avg Volume
- 1.48M
Get TickerSpark's AI analysis on BAYRY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our BAYRY coverage
Recent articles, reports, and earnings notes.
No research on BAYRY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BAYRY report →Similar companies
Peers in the same neighborhood.